Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
138.70B
Market cap138.70B
Price-Earnings ratio
13.04
Price-Earnings ratio13.04
Dividend yield
6.97%
Dividend yield6.97%
Average volume
65.03M
Average volume65.03M
High today
$24.69
High today$24.69
Low today
$24.21
Low today$24.21
Open price
$24.48
Open price$24.48
Volume
47.68M
Volume47.68M
52 Week high
$29.82
52 Week high$29.82
52 Week low
$20.92
52 Week low$20.92

PFE News

TipRanks 2h
Mixed options sentiment in Pfizer with shares down 0.51%

Mixed options sentiment in Pfizer (PFE), with shares down 12c near $24.39. Options volume roughly in line with average with 261k contracts traded and calls lead...

CNBC 3h
CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation

Albert Bourla, CEO of Pfizer, Charlie Scharf, Wells Fargo & Company CEO and Kathy Warden, Northrop Grumman Chair & CEO speak during the Invest in America Forum...

CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation
TipRanks 12h
Pfizer CEO believes U.S. pharma industry should collab with China, Reuters says

Pfizer (PFE) CEO Albert Bourla believes the U.S. pharmaceutical industry needs to collaborate with China’s, where faster processes have boosted it to 30% of glo...

Analyst ratings

60%

of 25 ratings
Buy
36%
Hold
60%
Sell
4%

More PFE News

Seeking Alpha 14h
Pfizer CEO touts China's 'dramatic speed' in biopharma, calls for U.S. collaboration

The U.S. pharmaceutical industry needs to collaborate with China, given the country's relatively faster drug development, Pfizer (NYSE:PFE) CEO Albert Bourla sa...

Pfizer CEO touts China's 'dramatic speed' in biopharma, calls for U.S. collaboration
Simply Wall St 1d
Is Pfizer’s Latest Drug Pricing Deal a Turning Point for 2025 Valuation?

Thinking about what to do with your Pfizer stock right now? You are not alone. The mood around this household pharmaceutical giant keeps shifting, and 2025 is p...

Is Pfizer’s Latest Drug Pricing Deal a Turning Point for 2025 Valuation?
Nasdaq 1d
Pfizer Shares Cross 7% Yield Mark

Looking at the universe of stocks we cover at Dividend Channel , in trading on Tuesday, shares of Pfizer Inc (Symbol: PFE) were yielding above the 7% mark based...

Pfizer Shares Cross 7% Yield Mark
24/7 Wall St. 1d
UPS, Pfizer, Verizon and Realty Income Offer Dividend Yields Above 5.5%

Home Investing Top Dividend Stocks Delivering Over 5% for True Financial Freedom Investing Top Dividend Stocks Delivering Over 5% for True Financial Freedom...

UPS, Pfizer, Verizon and Realty Income Offer Dividend Yields Above 5.5%
Benzinga 1d
Pfizer Seeks Expanded Use Approval For Breast Cancer Drug

Pfizer Inc. (NYSE:PFE) on Tuesday announced the initial results from a clinical trial called HER2CLIMB-05. This trial tested a new treatment for patients with...

Pfizer Seeks Expanded Use Approval For Breast Cancer Drug
24/7 Wall St. 1d
Dine Brands, Pfizer, and Wendy's Offer High Dividend Yields Above 6% After Sharp Stock Declines

Home Investing 3 Sizzling Ultra-High-Yield Stocks Under $50 With Upside Potential Investing 3 Sizzling Ultra-High-Yield Stocks Under $50 With Upside Potential...

Dine Brands, Pfizer, and Wendy's Offer High Dividend Yields Above 6% After Sharp Stock Declines
The Motley Fool 2d
Where Will Pfizer Be in 5 Years?

Pfizer is working hard to deal with some big headwinds it has coming up, but in five years, this should all be in the past. The 6.7% dividend yield on offer fr...

Where Will Pfizer Be in 5 Years?

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.